Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tony Velkov

Showing results (171-180 of 264) with videos related to

Pageof 27
Sort By:
Biochemical Pharmacology|January 2, 2021
Comparative metabolomics reveals key pathways associated with the synergistic activity of polymyxin B and rifampicin combination against multidrug-resistant Acinetobacter baumanniiJinxin Zhao, Mei-Ling Han, Yan Zhu, et al.
JCI Insight|August 28, 2020
Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combinationGuido Veit, Ariel Roldan, Mark A Hancock, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 9, 2017
A traceless reversible polymeric colistin prodrug to combat multidrug-resistant (MDR) gram-negative bacteriaChongyu Zhu, Elena K Schneider, Jiping Wang, et al.
International Journal of Pharmaceutics|July 17, 2018
Composite particle formulations of colistin and meropenem with improved in-vitro bacterial killing and aerosolization for inhalationSharad Mangal, Heejun Park, Lingfei Zeng, et al.
Organic & Biomolecular Chemistry|August 17, 2017
The first total synthesis and solution structure of a polypeptin, PE2, a cyclic lipopeptide with broad spectrum antibiotic activitySimon J Mountford, Biswaranjan Mohanty, Kade D Roberts, et al.
ACS Infectious Diseases|March 24, 2018
Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum BiomoleculesElena K Schneider-Futschik, Olivia K A Paulin, Daniel Hoyer, et al.
The Journal of Antimicrobial Chemotherapy|July 23, 2020
Lipid A profiling and metabolomics analysis of paired polymyxin-susceptible and -resistant MDR Klebsiella pneumoniae clinical isolates from the same patients before and after colistin treatmentSu Mon Aye, Irene Galani, Mei-Ling Han, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 5, 2024
Advancing Nitrile-Aminothiol Strategy for Dual and Sequential BioconjugationVarsha J Thombare, Yimin Wu, Kavya Pamulapati, et al.
Journal of Biomedical Nanotechnology|February 1, 2018
A Fresh Shine onCystic Fibrosis Inhalation Therapy: Antimicrobial Synergy of Polymyxin B in Combination with Silver NanoparticlesRaad Jasim, Elena K Schneider, Meiling Han, et al.
Computational and Structural Biotechnology Journal|March 14, 2022
Unique mechanistic insights into pathways associated with the synergistic activity of polymyxin B and caspofungin against multidrug-resistant <i>Klebsiella pneumoniae</i>Maytham Hussein, Labell J M Wong, Jinxin Zhao, et al.
Pageof 27

Showing results (171-180 of 264) with videos related to

Sort By:
Pageof 27
Biochemical Pharmacology|January 2, 2021
Comparative metabolomics reveals key pathways associated with the synergistic activity of polymyxin B and rifampicin combination against multidrug-resistant Acinetobacter baumanniiJinxin Zhao, Mei-Ling Han, Yan Zhu, et al.
JCI Insight|August 28, 2020
Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combinationGuido Veit, Ariel Roldan, Mark A Hancock, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 9, 2017
A traceless reversible polymeric colistin prodrug to combat multidrug-resistant (MDR) gram-negative bacteriaChongyu Zhu, Elena K Schneider, Jiping Wang, et al.
International Journal of Pharmaceutics|July 17, 2018
Composite particle formulations of colistin and meropenem with improved in-vitro bacterial killing and aerosolization for inhalationSharad Mangal, Heejun Park, Lingfei Zeng, et al.
Organic & Biomolecular Chemistry|August 17, 2017
The first total synthesis and solution structure of a polypeptin, PE2, a cyclic lipopeptide with broad spectrum antibiotic activitySimon J Mountford, Biswaranjan Mohanty, Kade D Roberts, et al.
ACS Infectious Diseases|March 24, 2018
Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum BiomoleculesElena K Schneider-Futschik, Olivia K A Paulin, Daniel Hoyer, et al.
The Journal of Antimicrobial Chemotherapy|July 23, 2020
Lipid A profiling and metabolomics analysis of paired polymyxin-susceptible and -resistant MDR Klebsiella pneumoniae clinical isolates from the same patients before and after colistin treatmentSu Mon Aye, Irene Galani, Mei-Ling Han, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|June 5, 2024
Advancing Nitrile-Aminothiol Strategy for Dual and Sequential BioconjugationVarsha J Thombare, Yimin Wu, Kavya Pamulapati, et al.
Journal of Biomedical Nanotechnology|February 1, 2018
A Fresh Shine onCystic Fibrosis Inhalation Therapy: Antimicrobial Synergy of Polymyxin B in Combination with Silver NanoparticlesRaad Jasim, Elena K Schneider, Meiling Han, et al.
Computational and Structural Biotechnology Journal|March 14, 2022
Unique mechanistic insights into pathways associated with the synergistic activity of polymyxin B and caspofungin against multidrug-resistant <i>Klebsiella pneumoniae</i>Maytham Hussein, Labell J M Wong, Jinxin Zhao, et al.
Pageof 27